NCT00712439View on ClinicalTrials.gov

Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

December 31, 2006

Conditions
Diabetic Peripheral Neuropathy
Interventions
DRUG

Gabapentin Extended Release tablets

DRUG

Placebo

Sponsors

Lead Sponsor

Depomed
All Listed Sponsors
lead

Depomed

INDUSTRY

NCT00712439 - Safety and Efficacy of Gabapentin in Diabetic Peripheral Neuropathy | Biotech Hunter | Biotech Hunter